Leveljump Healthcare Corp.
Symboli: JMPHF
PNK
0.0583
USDMarkkinahinta tänään
-4.9414
P/E-suhde
0.0009
PEG-suhde
5.62M
MRK Cap
- 0.00%
DIV Tuotto
Leveljump Healthcare Corp. (JMPHF) Tilinpäätöstiedotteet
Tase
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 0.1 | 0.8 | 0.9 | ||||
balance-sheet.row.short-term-investments | 0 | -0.7 | 1.3 | 0 | ||||
balance-sheet.row.net-receivables | 0 | 3 | 1.4 | 0.6 | ||||
balance-sheet.row.inventory | 0 | 0.1 | 0.1 | 0.1 | ||||
balance-sheet.row.other-current-assets | 0 | 0.2 | 0.3 | 0.3 | ||||
balance-sheet.row.total-current-assets | 0 | 3.4 | 2.6 | 1.9 | ||||
balance-sheet.row.property-plant-equipment-net | 0 | 1.3 | 0 | 0.1 | ||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.intangible-assets | 0 | 6.1 | 0 | 0 | ||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 6.1 | 0 | 0 | ||||
balance-sheet.row.long-term-investments | 0 | 2.5 | 1.4 | 0 | ||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.other-non-current-assets | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.total-non-current-assets | 0 | 9.9 | 1.5 | 0.1 | ||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.total-assets | 0 | 13.3 | 4.1 | 2 | ||||
balance-sheet.row.account-payables | 0 | 1.3 | 0.7 | 0.9 | ||||
balance-sheet.row.short-term-debt | 0 | 0.6 | 0 | 0 | ||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.long-term-debt-total | 0 | 3.6 | 0 | 0.1 | ||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||
balance-sheet.row.other-current-liab | 0 | 0.8 | 0.9 | 0.4 | ||||
balance-sheet.row.total-non-current-liabilities | 0 | 4 | 0.2 | 0.2 | ||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.capital-lease-obligations | 0 | 0.3 | 0 | 0.1 | ||||
balance-sheet.row.total-liab | 0 | 7 | 2.1 | 1.6 | ||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.common-stock | 0 | 15.6 | 12.9 | 11 | ||||
balance-sheet.row.retained-earnings | 0 | -14.4 | -14.6 | -12.4 | ||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 15.3 | 13.1 | 10 | ||||
balance-sheet.row.other-total-stockholders-equity | 0 | -10.2 | -9.4 | -8.2 | ||||
balance-sheet.row.total-stockholders-equity | 0 | 6.3 | 2 | 0.3 | ||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 13.3 | 4.1 | 2 | ||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.total-equity | 0 | 6.3 | 2 | 0.3 | ||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||
Total Investments | 0 | 1.9 | 1.1 | 0 | ||||
balance-sheet.row.total-debt | 0 | 4.2 | 0 | 0.1 | ||||
balance-sheet.row.net-debt | 0 | 4.1 | -0.7 | -0.8 |
Kassavirtalaskelma
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 0.2 | -2.2 | -11.6 | ||||
cash-flows.row.depreciation-and-amortization | 0 | 0.2 | 0 | 0 | ||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | ||||
cash-flows.row.stock-based-compensation | 0 | 0.3 | 0.7 | 0.1 | ||||
cash-flows.row.change-in-working-capital | 0 | 0 | -0.3 | -0.6 | ||||
cash-flows.row.account-receivables | 0 | -0.5 | -0.2 | 0 | ||||
cash-flows.row.inventory | 0 | 0.1 | 0 | -0.4 | ||||
cash-flows.row.account-payables | 0 | 0.2 | 0 | -0.1 | ||||
cash-flows.row.other-working-capital | 0 | 0.1 | -0.1 | -0.1 | ||||
cash-flows.row.other-non-cash-items | 0 | -1 | 0 | 9.1 | ||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -1.6 | 0 | 0 | ||||
cash-flows.row.acquisitions-net | 0 | -4 | 0 | 0.2 | ||||
cash-flows.row.purchases-of-investments | 0 | -0.1 | 0 | 0 | ||||
cash-flows.row.sales-maturities-of-investments | 0 | -1.1 | 0 | 0.1 | ||||
cash-flows.row.other-investing-activites | 0 | 1.1 | 0 | 0 | ||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -5.8 | 0 | 0.3 | ||||
cash-flows.row.debt-repayment | 0 | -0.4 | -0.1 | -0.1 | ||||
cash-flows.row.common-stock-issued | 0 | 2.4 | 1.6 | 3.4 | ||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||
cash-flows.row.other-financing-activites | 0 | 3.4 | 0.1 | 0.2 | ||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 5.5 | 1.6 | 3.5 | ||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||
cash-flows.row.net-change-in-cash | 0 | -0.7 | -0.1 | 0.9 | ||||
cash-flows.row.cash-at-end-of-period | 0 | 0.1 | 0.8 | 0.9 | ||||
cash-flows.row.cash-at-beginning-of-period | 0 | 0.8 | 0.9 | 0 | ||||
cash-flows.row.operating-cash-flow | 0 | -0.3 | -1.8 | -3 | ||||
cash-flows.row.capital-expenditure | 0 | -1.6 | 0 | 0 | ||||
cash-flows.row.free-cash-flow | 0 | -2 | -1.8 | -3 |
Tuloslaskelmarivi
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 9.2 | 6.7 | 5.5 | ||||
income-statement-row.row.cost-of-revenue | 0 | 6.7 | 5.4 | 4.4 | ||||
income-statement-row.row.gross-profit | 0 | 2.5 | 1.4 | 1 | ||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||
income-statement-row.row.research-development | 0 | - | - | - | ||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||
income-statement-row.row.other-expenses | 0 | 0 | 0 | 0 | ||||
income-statement-row.row.operating-expenses | 0 | 3.3 | 3.5 | 3.2 | ||||
income-statement-row.row.cost-and-expenses | 0 | 10 | 8.9 | 7.6 | ||||
income-statement-row.row.interest-income | 0 | 0 | 0 | 0 | ||||
income-statement-row.row.interest-expense | 0 | 0.1 | 0 | 0.1 | ||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||
income-statement-row.row.total-other-income-expensenet | 0 | 1.2 | 0 | -9.3 | ||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0 | 0 | ||||
income-statement-row.row.total-operating-expenses | 0 | 1.2 | 0 | -9.3 | ||||
income-statement-row.row.interest-expense | 0 | 0.1 | 0 | 0.1 | ||||
income-statement-row.row.depreciation-and-amortization | 0 | 0.2 | 0 | 0 | ||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||
income-statement-row.row.operating-income | 0 | -0.6 | -1.7 | 0.1 | ||||
income-statement-row.row.income-before-tax | 0 | 0.2 | -2.2 | -11.6 | ||||
income-statement-row.row.income-tax-expense | 0 | 0.2 | 0.1 | 0.1 | ||||
income-statement-row.row.net-income | 0 | 0.2 | -2.2 | -11.6 |
Usein kysytty kysymys
Mikä on Leveljump Healthcare Corp. (JMPHF) taseen loppusumma?
Leveljump Healthcare Corp. (JMPHF) kokonaisvarat ovat 13258155.000.
Mikä on yrityksen vuotuinen liikevaihto?
Vuotuinen liikevaihto on N/A.
Mikä on yrityksen voittomarginaali?
Yrityksen voittomarginaali on 0.274.
Mikä on yrityksen vapaa kassavirta?
Vapaa kassavirta on -0.051.
Mikä on yrityksen nettovoittomarginaali?
Nettovoittomarginaali on -0.097.
Mikä on yrityksen kokonaistulot?
Kokonaisliikevaihto on -0.046.
Mikä on Leveljump Healthcare Corp. (JMPHF) nettovoitto (nettotulos)?
Nettovoitto (nettotulos) on 234767.000.
Mikä on yrityksen kokonaisvelka?
Kokonaisvelka on 4182540.000.
Mikä on yrityksen toimintakulujen määrä?
Toimintakulut ovat 3267474.000.
Mikä on yrityksen kassan määrä?
Yrityksen kassavarat ovat 0.000.